Skip to Content

T29 (Carbamazepine extended-release 400 mg)

Pill imprint T29 has been identified as Carbamazepine extended-release 400 mg.

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy; borderline personality disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbamazepine extended-release 400 mg T29
Carbamazepine extended-release 400 mg T29  Front
Carbamazepine extended-release 400 mg T29  Back
Discount Card Promo
Carbamazepine extended-release
400 mg
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Taro Pharmaceutical Industries Ltd.
National Drug Code (NDC):
Inactive Ingredients:
corn starch
diethyl phthalate
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-6074 Physicians Total Care Inc (repackager)
60429-0938 Golden State Medical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.